These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22356277)

  • 1. Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.
    Musharraf SG; Hashmi N; Choudhary MI; Rizvi N; Usman A; Atta-ur-Rahman
    Biomarkers; 2012 May; 17(3):223-30. PubMed ID: 22356277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis for detecting serum biomarkers related to smoking in humans.
    Xiao D; Zhao LJ; Chu SL; Jing H; Wang C
    Chin Med J (Engl); 2012 Sep; 125(17):3027-32. PubMed ID: 22932174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum proteomic profiling before and after cervical cancer surgery].
    Shao ZY; Zheng ZG; Lou HM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):374-8. PubMed ID: 19573315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
    Harezlak J; Wang M; Christiani D; Lin X
    Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu T; Xue R; Huang X; Zhang D; Dong L; Wu H; Shen X
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):542-50. PubMed ID: 21659380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
    Umar A; Dalebout JC; Timmermans AM; Foekens JA; Luider TM
    Proteomics; 2005 Jul; 5(10):2680-8. PubMed ID: 15892168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of serum proteins in the patients of lung adenocarcinoma by the method of magnetic bead based sample fractionation and MALDI-TOF-MS].
    Liu D; Liu LX; Yuan Q; Li XL; Huang N; Yang XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):498-500, 556. PubMed ID: 20629331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis.
    Marvin-Guy LF; Duncan P; Wagnière S; Antille N; Porta N; Affolter M; Kussmann M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1099-108. PubMed ID: 18335464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.